Details for New Drug Application (NDA): 021697
✉ Email this page to a colleague
The generic ingredient in VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is conivaptan hydrochloride. Additional details are available on the conivaptan hydrochloride profile page.
Summary for 021697
| Tradename: | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER |
| Applicant: | Cumberland |
| Ingredient: | conivaptan hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/4ML (5MG/ML) | ||||
| Approval Date: | Dec 29, 2005 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/100ML (0.2MG/ML) | ||||
| Approval Date: | Oct 8, 2008 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 021697
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cumberland | VAPRISOL | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-001 | Dec 29, 2005 | 5,723,606 | ⤷ Get Started Free |
| Cumberland | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-002 | Oct 8, 2008 | 5,723,606 | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
